Cargando…

The Utility of Potassium Monitoring in Gender-Diverse Adolescents Taking Spironolactone

CONTEXT: Current guidelines recommend close monitoring of electrolytes in transgender patients using spironolactone given the risk of hyperkalemia from mineralocorticoid antagonism. In patients taking spironolactone for other conditions, the rate of hyperkalemia is low, and the utility of frequent m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millington, Kate, Liu, Enju, Chan, Yee-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497918/ https://www.ncbi.nlm.nih.gov/pubmed/31065620 http://dx.doi.org/10.1210/js.2019-00030

Ejemplares similares

SUN-242 The Utility of Potassium Monitoring in Transgender Adolescents Taking Spironolactone
por: Millington, Kate, et al.
Publicado: (2019)

The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
por: Hayes, Hailey, et al.
Publicado: (2022)

SAT379 Potassium Levels in Women with PCOS Using Spironolactone for Long-term
por: Oliveira, Thais Areias, et al.
Publicado: (2023)

SAT376 Luteinizing Hormone Secretion in Hyperandrogenic Girls Taking Spironolactone or Metformin
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2023)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients
por: Zeng, Fanfang, et al.
Publicado: (2019)

ODP425 Potassium Level Trends in Trans Females Using Spironolactone: A Retrospective Chart Review
por: Gupta, Pranav, et al.
Publicado: (2022)

Idiopathic or iatrogenic membranous glomerulonephritis? A case of spironolactone-induced membranous glomerulonephritis
por: Inaba, Akimichi, et al.
Publicado: (2011)

The Utilization of Spironolactone in Heart Failure Patients at a Tertiary Hospital in Saudi Arabia
por: Alotaibi, Abdulmalik S, et al.
Publicado: (2020)

Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease
por: Wong, Calvin W, et al.
Publicado: (2023)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
por: Wong, Calvin W, et al.
Publicado: (2023)

A Randomized Trial of Sitagliptin and Spironolactone With Combination Therapy in Hospitalized Adults With COVID-19
por: Abbasi, Farhad, et al.
Publicado: (2022)

Effect of spironolactone on pain responses in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2010)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Imatinib and spironolactone suppress hepcidin expression
por: Mleczko-Sanecka, Katarzyna, et al.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

Radiofrequency catheter ablation combined with spironolactone in the treatment of atrial fibrillation: A single‐center randomized controlled study
por: Wang, Weiwei, et al.
Publicado: (2021)

The effect of spironolactone on diastolic function in haemodialysis patients
por: Hauser, T., et al.
Publicado: (2021)

Low Bone Mineral Density in Early Pubertal Transgender/Gender Diverse Youth: Findings From the Trans Youth Care Study
por: Lee, Janet Y, et al.
Publicado: (2020)

Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
por: Sanomachi, Tomomi, et al.
Publicado: (2019)

Serous Retinal Detachment Associated with Dome-Shaped Macula and Staphyloma Edge in Myopic Patients before and after Treatment with Spironolactone
por: Fernández-Vega Sanz, Álvaro, et al.
Publicado: (2016)

DRESS Syndrome Secondary to Spironolactone with Atypical Presentation
por: Bains, Anupama, et al.
Publicado: (2020)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial
por: Squire, Iain B., et al.
Publicado: (2022)

Does board gender diversity weaken or strengthen executive risk-taking incentives?
por: Chatjuthamard, Pattanaporn, et al.
Publicado: (2021)

Endorsement of gender stereotypes in gender diverse and cisgender adolescents and their parents
por: deMayo, Benjamin, et al.
Publicado: (2022)

Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction
por: LIU, YAN, et al.
Publicado: (2014)

Risk Perception and Risk-Taking Behaviour during Adolescence: The Influence of Personality and Gender
por: Reniers, Renate L. E. P., et al.
Publicado: (2016)

Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review
por: Rajashekar, Shriya, et al.
Publicado: (2022)

Neural Representation of Parental Monitoring and Links to Adolescent Risk Taking
por: Lee, Tae-Ho, et al.
Publicado: (2019)

Use, tolerability and compliance of spironolactone in the treatment of heart failure
por: Lachaine, Jean, et al.
Publicado: (2011)

Agranulocytosis Associated With Spironolactone Therapy: A Case Report
por: Fershko, Adam A., et al.
Publicado: (2011)

S47. ADD-ON SPIRONOLACTONE FOR THE TREATMENT OF SCHIZOPHRENIA (SPIRO TREAT)
por: Roeh, Astrid, et al.
Publicado: (2018)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Spironolactone and Cardiac Arrhythmias in Hemodialysis Patients: Helpful or Harmful?
por: Pun, Patrick H.
Publicado: (2023)

Gender Diversity and Brain Morphology Among Adolescents
por: Xerxa, Yllza, et al.
Publicado: (2023)

Gender differences in ankylosing spondylitis-associated cumulative healthcare utilization: a population-based cohort study
por: Chen, Hsin-Hua, et al.
Publicado: (2011)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
por: Coffman, Melissa, et al.
Publicado: (2021)

Evaluation of early left-sided cardiac reverse remodeling under combined therapy of sacubitril-valsartan and spironolactone compared with angiotensin-converting enzyme inhibitors and spironolactone
por: Sacharczuk, Wioletta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u5mtp8gecg1j284516j7459vsq